Predictive Factors of Tumor Response and Prognostic Factors of Survival during Lung Cancer Chemotherapy
- 1 January 1998
- journal article
- Published by Wiley in Cancer Detection Prevention
- Vol. 22 (4) , 293-304
- https://doi.org/10.1046/j.1525-1500.1998.cdoa43.x
Abstract
The aim of this study was (i) to determine predictive factors of a complete response to chemotherapy in small cell lung cancer (SCLC) and predictive factors of an objective response in non-small cell lung cancer (NSCLC) and (ii) to determine whether prognostic factors are different with regard to treatment response and survival. Ninety-nine patients with SCLC and two hundred and two patients with NSCLC received chemotherapy. The following variables were recorded prior to treatment: tumor, node, metastasis status, performance status, body weight loss, blood leukocyte count, serum sodium, serum albumin, lactate dehydrogenase (LDH), alkaline phosphatase, serum NSE, serum TPS, and serum CYFRA 21-1. Tumor response was analyzed at the 10th week. Analysis of survival were done using the landmark method. Hazard ratios of the significant prognostic variables of survival were calculated using the Cox's model. Odds ratios of the significant predicting factors of response were calculated by stepwise logistic regression. In SCLC, the significant determinants of poor survival were: lack of complete response (HR: 2.04), weight loss (HR: 1.76), high serum LDH level (HR: 1.64), and high serum TPS level (HR: 2.47). A high serum TPS level was the only factor among those studied able to predict lack of achievement of complete response (OR: 0.39). In NSCLC, significant determinants of poor survival were: no objective response (HR: 2.28), poor performance status (HR: 2.52), presence of metastases (HR: 1.51), and high serum CYFRA 21-1 level (HR: 1.84). On the other hand, a high serum TPS level (OR: 0.50), the presence of metastases (OR: 0.45), and a leukocyte blood count over 10,000/microl (OR: 0.43) were independent determinants for a patient not to achieve an objective response. We concluded that the predictive factors of complete response in SCLC remain to be defined. On the other hand, in NSCLC three variables contribute to the prediction of an objective response. Finally, determinants of survival differ from predictive factors of response.Keywords
This publication has 22 references indexed in Scilit:
- Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS.American Journal of Respiratory and Critical Care Medicine, 1996
- Lung cancer chemotherapy. Response-survival relationship depends on the method of chest tumor response evaluation.American Journal of Respiratory and Critical Care Medicine, 1996
- Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancerBritish Journal of Cancer, 1994
- Clinical evaluation of serum tissue polypeptide-specific antigen (TPS) in non-small cell lung cancerEuropean Journal Of Cancer, 1994
- Chemotherapy in advanced non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Usefulness of Tissue Polypeptide Antigen in Staging, Monitoring, and Prognosis of Lung CancerChest, 1988
- Neuron-specific enolase (NSE): A useful marker in small cell lung cancerLung Cancer, 1987
- Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.Journal of Clinical Oncology, 1986
- A New International Staging System for Lung CancerChest, 1986
- The World Health Organization Histological Typing of Lung Tumours: Second EditionAmerican Journal of Clinical Pathology, 1982